In diesem digitalen Quellenverzeichnis finden Sie die 668 Literaturangaben zum Buch „90 plus und fit wie ein Turnschuh“.
Die Sammlung umfasst wissenschaftliche Originalarbeiten, Übersichtsarbeiten, Leitlinien sowie weiterführende Fachliteratur. Soweit vorhanden, sind die Veröffentlichungen über ihre DOI oder die jeweilige Internetadresse direkt erreichbar.
Über die Suchfunktion können Sie gezielt nach Quellen-Nummern, Autoren oder Veröffentlichungstiteln suchen.
668 Quellen gefunden · Anzeige 501–520
Cosford PA, Leng GC, Thomas J. Screening for abdominal aortic aneurysm. Cochrane Vascular Group, editor. Cochrane Database of Systematic Reviews. 2007 Apr 18. DOI: 10.1002/14651858.CD002945.pub2
Originalquelle öffnen ↗The National Lung Screening Trial Research Team. Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening. N Engl J Med. 2011 Aug 4;365(5):395–409. DOI: 10.1056/NEJMoa1102873
Originalquelle öffnen ↗De Koning HJ, Van Der Aalst CM, De Jong PA, Scholten ET, Nackaerts K, Heuvelmans MA, et al. Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial. N Engl J Med. 2020 Feb 6;382(6):503–13. DOI: 10.1056/NEJMoa1911793
Originalquelle öffnen ↗Zheng S, Schrijvers JJA, Greuter MJW, Kats-Ugurlu G, Lu W, De Bock GH. Effectiveness of Colorectal Cancer (CRC) Screening on All-Cause and CRC-Specific Mortality Reduction: A Systematic Review and Meta-Analysis. Cancers. 2023 Mar 24;15(7):1948. DOI: 10.3390/cancers15071948
Originalquelle öffnen ↗Myers ER, Moorman P, Gierisch JM, Havrilesky LJ, Grimm LJ, Ghate S, et al. Benefits and Harms of Breast Cancer Screening: A Systematic Review. JAMA. 2015 Oct 20;314(15):1615. DOI: 10.1001/jama.2015.13183
Originalquelle öffnen ↗US Preventive Services Task Force, Owens DK, Davidson KW, Krist AH, Barry MJ, Cabana M, et al. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA -Related Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2019 Aug 20;322(7):652. DOI: 10.1001/jama.2019.10987
Originalquelle öffnen ↗Peirson L, Fitzpatrick-Lewis D, Ciliska D, Warren R. Screening for cervical cancer: a systematic review and meta-analysis. Syst Rev. 2013 Dec;2(1):35. DOI: 10.1186/2046-4053-2-35
Originalquelle öffnen ↗Jansen EEL, Zielonke N, Gini A, Anttila A, Segnan N, Vokó Z, et al. Effect of organised cervical cancer screening on cervical cancer mortality in Europe: a systematic review. European Journal of Cancer. 2020 Mar;127:207–23. DOI: 10.1016/j.ejca.2019.12.013
Originalquelle öffnen ↗Ilic D, Djulbegovic M, Jung JH, Hwang EC, Zhou Q, Cleves A, et al. Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis. BMJ. 2018 Sep 5;k3519. DOI: 10.1136/bmj.k3519
Originalquelle öffnen ↗Roobol MJ, De Vos II, Månsson M, Godtman RA, Talala KM, Den Hond E, et al. European Study of Prostate Cancer Screening – 23-Year Follow-up. N Engl J Med. 2025 Oct 30;393(17):1669–80. DOI: 10.1056/NEJMoa2503223
Originalquelle öffnen ↗Graham NJ, Souter LH, Salami SS. A systematic review of family history, race/ethnicity, and genetic risk on prostate cancer detection and outcomes: Considerations in PSA-based screening. Urologic Oncology: Seminars and Original Investigations. 2025 Jan;43(1):29–40. DOI: 10.1016/j.urolonc.2024.06.002
Originalquelle öffnen ↗ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, et al. 2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes–2023. Diabetes Care. 2023 Jan 1;46(Supplement_1):S19–40. DOI: 10.2337/dc23-S002
Originalquelle öffnen ↗Tabák AG, Herder C, Rathmann W, Brunner EJ, Kivimäki M. Prediabetes: a high-risk state for diabetes development. The Lancet. 2012 Jun;379(9833):2279–90. DOI: 10.1016/S0140-6736(12)60283-9
Originalquelle öffnen ↗Tsimikas S. A Test in Context: Lipoprotein(a). Journal of the American College of Cardiology. 2017 Feb;69(6):692–711. DOI: 10.1016/j.jacc.2016.11.042
Originalquelle öffnen ↗Bittner VA, Szarek M, Aylward PE, Bhatt DL, Diaz R, Edelberg JM, et al. Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome. Journal of the American College of Cardiology. 2020 Jan;75(2):133–44. DOI: 10.1016/j.jacc.2019.10.057
Originalquelle öffnen ↗Chapman LE, Darling AL, Brown JE. Association between metformin and vitamin B12 deficiency in patients with type 2 diabetes: A systematic review and meta-analysis. Diabetes & Metabolism. 2016 Nov;42(5):316–27. DOI: 10.1016/j.diabet.2016.03.008
Originalquelle öffnen ↗Bischoff-Ferrari HA, Willett WC, Wong JB, Stuck AE, Staehelin HB, Orav EJ, et al. Prevention of Nonvertebral Fractures With Oral Vitamin D and Dose Dependency: A Meta-analysis of Randomized Controlled Trials. Arch Intern Med. 2009 Mar 23;169(6):551. DOI: 10.1001/archinternmed.2008.600
Originalquelle öffnen ↗Biondi B, Cooper DS. The Clinical Significance of Subclinical Thyroid Dysfunction. Endocrine Reviews. 2008 Feb 1;29(1):76–131. DOI: 10.1210/er.2006-0043
Originalquelle öffnen ↗Kronenberg F, Mora S, Stroes ESG, Ference BA, Arsenault BJ, Berglund L, et al. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement. European Heart Journal. 2022 Oct 14;43(39):3925–46. DOI: 10.1093/eurheartj/ehac361
Originalquelle öffnen ↗Kamstrup PR, Neely RDG, Nissen S, Landmesser U, Haghikia A, Costa-Scharplatz M, et al. Lipoprotein(a) and cardiovascular disease: sifting the evidence to guide future research. European Journal of Preventive Cardiology. 2024 May 11;31(7):903–14. DOI: 10.1093/eurjpc/zwae032
Originalquelle öffnen ↗